LF
AXSM icon

Lee Financial’s Axsome Therapeutics AXSM Stock Holding History

Lee Financial’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-16
Closed -$1.27K – 210
2023
Q4 		$1.27K Hold
16
– – ﹤0.01% 791
2023
Q3 		$1.12K Hold
16
– – ﹤0.01% 766
2023
Q2 		$1.15K Hold
16
– – ﹤0.01% 716
2023
Q1 		$987 Hold
16
– – ﹤0.01% 737
2022
Q4 		$1.23K Hold
16
– – ﹤0.01% 761
2022
Q3 		$1K Buy
+16
New +$799 ﹤0.01% 734

Other funds holding AXSM

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Lee Financial's AXSM Position: Q1 2024 in Review

Lee Financial sold out of Axsome Therapeutics (AXSM) in Q1 2024, closing a stake of 16 shares — an estimated $1.27K sold.

Lee Financial first reported a position in AXSM in Q3 2022 and held it in 6 quarters. The position peaked at $1.27K in Q4 2023. 259 funds tracked by Wall St. Rank hold AXSM as of Q1 2024.

  • Lee Financial reported no remaining Axsome Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Lee Financial sold 16 Axsome Therapeutics shares in Q1 2024, an estimated $1.27K.
  • Lee Financial first reported a position in Axsome Therapeutics in Q3 2022 and held it in 6 quarters.
  • Lee Financial's Axsome Therapeutics position peaked at $1.27K in Q4 2023.
  • 259 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2024.

Based on Lee Financial's 13F filing for Q1 2024, filed 15 May 2024.